/PRNewswire/ The integration of artificial intelligence (AI) in the genomics industry is set to revolutionize the field in the near future. AI has the.
Tempus Receives U S FDA Approval for xT CDx, a NGS-Based In Vitro Diagnostic Device webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published a.
The FDA has approved xT CDx, a 648-gene next-generation sequencing assay for solid tumor profiling, and companion diagnostic for patients with colorectal cancer.
/PRNewswire/ Immunovia AB (publ), reg. no. 556730-4299, hereby gives notice that the Annual General Meeting ("AGM") will take place on Friday 26th May 2023.